Biogen to buy San Francisco startup developing a drug for kidney disease for $1.2B
Billerica diagnostics firm to pay $42M for inaccurate blood tests
Tufts Medicine cuts 174 employees as part of 'multi-faceted plan'
Genzyme vet named to lead startup developing vaccines-in-a-patch
Five things: Drone expansion; NIH, NSF grants; radiopharmaceuticals and my runway moment
Desktop versie